<![CDATA[Hypertriglyceridemia]]> https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/diseases-conditions/hypertriglyceridemia Sat, 14 Mar 2026 18:41:21 +0000 Zend_Feed http://blogs.law.harvard.edu/tech/rss <![CDATA[Hypertriglyceridemia - Pipeline Review, H2 2016]]> https://www.leadingmarketresearch.com/hypertriglyceridemia-pipeline-review-h2-2016

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Hypertriglyceridemia Overview 9
Therapeutics Development 10
Pipeline Products for Hypertriglyceridemia - Overview 10
Pipeline Products for Hypertriglyceridemia - Comparative Analysis 11
Hypertriglyceridemia - Therapeutics under Development by Companies 12
Hypertriglyceridemia - Therapeutics under Investigation by Universities/Institutes 14
Hypertriglyceridemia - Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Hypertriglyceridemia - Products under Development by Companies 18
Hypertriglyceridemia - Products under Investigation by Universities/Institutes 19
Hypertriglyceridemia - Companies Involved in Therapeutics Development 20
Acasti Pharma Inc 20
Akcea Therapeutics Inc 21
Allergan Plc 22
Alnylam Pharmaceuticals Inc 23
Arisaph Pharmaceuticals Inc 24
AstraZeneca Plc 25
BASF SE 26
Cardax Inc 27
Catabasis Pharmaceutical...

$2,000.00
]]> Fri, 07 Apr 2017 13:51:23 +0000